1 active not recruiting, 1 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Lipodystrophy, Partial, Acquired: new trials by email Literature Review of Lipodystrophy, Partial, Acquired trials Research Report on Lipodystrophy, Partial, Acquired
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL metreleptin, Placebo - Partial Lipodystrophy | Phase 3 | Active not recruiting | Chiesi Farmaceutici S.p.A. | 69 | 2021-12-17 | 2026-06-15 |
| Trial of Leptin Replacement Therapy in Patients With Lipodystrophy Leptin, Placebo - Hypoleptinemia, Generalized Lipodystrophy | Phase 2 / Phase 3 | Completed | University of Texas Southwestern Medical Center | 25 | 2006-04-01 | 2024-03-27 |
Insulin Resistance (1) · Lipodystrophy (1) · Lipodystrophy, Congenital Generalized (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Lipid Metabolism Disorders (1) · Lipid Metabolism, Inborn Errors (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Nutritional and Metabolic Diseases (1) · Skin Diseases (1) · Skin Diseases, Metabolic (1) · Skin and Connective Tissue Diseases (1)
Leptin (1) · metreleptin (1) · recombinant methionyl human leptin (1)
Chiesi Farmaceutici S.p.A. (1) · University of Texas Southwestern Medical Center (1)
United States (2) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Israel (1) · Netherlands (1) · Poland (1) · Spain (1)